brand logo

Am Fam Physician. 2016;93(8):704a-705

Clinical Question

Is the high-sensitivity troponin I assay accurate in identifying patients with suspected acute coronary syndromes who are at low risk of cardiac events?

Bottom Line

The high-sensitivity troponin I assay used in this study was fairly accurate in identifying patients with chest pain who are at low risk of cardiac events. (Level of Evidence = 1c−)

Synopsis

These authors conducted a two-part study in adults presenting to the emergency department with suspected acute coronary syndromes. Each of the participating departments had been randomized into the standard care arms of trials designed to determine if high-sensitivity troponin I levels will influence care and improve outcomes. In the first part, the derivation cohort, the researchers evaluated nearly 4,900 adults, 16% of whom had an acute myocardial infarction (MI) at the time of emergency department presentation and an additional handful who had a subsequent acute MI or died (1% and 2%, respectively) within 30 days. From this cohort, they determined that to achieve a 99.5% negative predictive value (determined a priori) a threshold value for high-sensitivity troponin I should be 5 nanograms per liter. In the second part of the study, the validation cohort, the researchers used two different groups and followed more than 1,400 patients for up to one year after enrollment. Approximately 0.5% of the patients with a low high-sensitivity troponin I level had an acute MI—nearly 100% negative predictive value. The researchers evaluated the performance across many subgroups (sex, age, prior heart disease, and so forth) and found no significant differences. After one year, 0.3% of the patients with a low high-sensitivity troponin I level had an incident acute MI and 0.3% had a cardiac death compared with 1.3% and 2.2% in those with elevated high-sensitivity troponin I level, respectively.

Study design: Cohort (prospective)

Funding source: Government

Setting: Emergency department

Reference: ShahASAnandASandovalYet alHigh-STEACS investigatorsHigh-sensitivity cardiac troponin I at presentation in patients with suspected acute coronary syndrome: a cohort study. Lancet2015; 386( 10012): 2481– 2488.

POEMs (patient-oriented evidence that matters) are provided by Essential Evidence Plus, a point-of-care clinical decision support system published by Wiley-Blackwell. For more information, see http://www.essentialevidenceplus.com. Copyright Wiley-Blackwell. Used with permission.

For definitions of levels of evidence used in POEMs, see http://www.essentialevidenceplus.com/product/ebm_loe.cfm?show=oxford.

To subscribe to a free podcast of these and other POEMs that appear in AFP, search in iTunes for “POEM of the Week” or go to http://goo.gl/3niWXb.

This series is coordinated by Sumi Sexton, MD, editor-in-chief.

A collection of POEMs published in AFP is available at https://www.aafp.org/afp/poems.

Continue Reading


More in AFP

Copyright © 2016 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP.  See permissions for copyright questions and/or permission requests.